What is it about?

The authors addressed concerns about the statistical methods used in our study article: ‘Effects of Zibotentan and Dapagliflozin on Fluid Retention in Patients with CKD: Need More Evidence’. We confirmed that our original method was appropriate and also re-analyzed our data using a different method to account for potential timing issues in how the data was collected. The results from both methods were similar, strengthening the conclusions of the original study.

Featured Image

Read the Original

This page is a summary of: Authors' Reply: Effects of Zibotentan and Dapagliflozin on Fluid Retention in Patients with CKD: Need More Evidence, Journal of the American Society of Nephrology, November 2024, Wolters Kluwer Health,
DOI: 10.1681/asn.0000000553.
You can read the full text:

Read

Contributors

Be the first to contribute to this page